A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic

Biotechnology (N Y). 1995 May;13(5):498-503. doi: 10.1038/nbt0595-498.

Abstract

We previously reported the production of limited quantities of biologically active recombinant human lactoferrin in the filamentous fungus Aspergillus oryzae. In the present study, we report a modification of this production system combined with a classical strain improvement program that has enabled production of levels of recombinant human lactoferrin in excess of 2 g/l. The protein was expressed in Aspergillus awamori as a glucoamylase fusion polypeptide which was secreted into the growth medium and processed to mature human lactoferrin by an endogenous KEX-2 peptidase. The recombinant protein retains full biological activity in terms of its ability to bind iron and human enterocyte receptors. Furthermore, the recombinant protein functions as a potent broad spectrum antimicrobial protein.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / biosynthesis*
  • Anti-Bacterial Agents / pharmacology
  • Aspergillus
  • Caco-2 Cells
  • Escherichia coli / drug effects
  • Female
  • Glucan 1,4-alpha-Glucosidase / genetics
  • Glycosylation
  • Humans
  • Hydrogen-Ion Concentration
  • Lactoferrin / biosynthesis*
  • Lactoferrin / pharmacology
  • Mice
  • Mice, Inbred ICR
  • Microbial Sensitivity Tests
  • Promoter Regions, Genetic
  • Protein Binding
  • Recombinant Fusion Proteins / biosynthesis*
  • Recombinant Fusion Proteins / pharmacology

Substances

  • Anti-Bacterial Agents
  • Recombinant Fusion Proteins
  • Glucan 1,4-alpha-Glucosidase
  • Lactoferrin